Board Of Directors
Veterinary Recombinant Biologics
Mirataz™ (mirtazapine transdermal ointment)
Zimeta™ (dipyrone injection)
epoCat™ (feline recombinant erythropoietin)
SEC Filings and Governance
You are here:
We’d love to hear from you! Send us an email or give us a call, we would be happy to answer your questions.
Please provide an email address where we can contact you
Please subscribe me to your mailing list
Yes, I would occasionally like to receive communications about KindredBio products, news and company updates.
No, thank you.
This iframe contains the logic required to handle AJAX powered Gravity Forms.
1555 Bayshore Hwy, Suite 200
Burlingame, California 94010
Tel (650) 701-7901
Find us on Social Media:
Looking for information about Investor Relations?
KindredBio Announces Pricing of Public Offering
July 12, 2017 - 8:44 am
KindredBio Announces Proposed Public Offering of Common Stock
July 11, 2017 - 4:16 pm
Kindred Biosciences Announces Acquisition of Kansas Manufacturing Plant and Execution of Commercial Manufacturing Agreement for Zimeta
June 26, 2017 - 7:33 am
Event: Kindred Biosciences to Present at 7th Annual LD Micro Invitational
May 24, 2017 - 10:51 am
Event: Kindred Biosciences to Announce First Quarter 2017 Financial Results
April 24, 2017 - 8:57 am
Event: Kindred Biosciences to Present at 2017 Jefferies Animal Health Summit
March 16, 2017 - 4:02 pm
Announcing our new website:
Scroll to top